A proof of concept for structure-based vaccine design targeting RSV in humans

被引:279
作者
Crank, Michelle C. [1 ]
Ruckwardt, Tracy J. [1 ]
Chen, Man [1 ]
Morabito, Kaitlyn M. [1 ]
Phung, Emily [1 ,2 ]
Costner, Pamela J. [1 ]
Holman, LaSonji A. [1 ]
Hickman, Somia P. [1 ]
Berkowitz, Nina M. [1 ]
Gordon, Ingelise J. [1 ]
Yamshchikov, Galina V. [1 ]
Gaudinski, Martin R. [1 ]
Kumar, Azad [1 ]
Chang, Lauren A. [1 ]
Moin, Syed M. [1 ]
Hill, Juliane P. [1 ,5 ]
DiPiazza, Anthony T. [1 ]
Schwartz, Richard M. [1 ,6 ]
Kueltzo, Lisa [1 ]
Cooper, Jonathan W. [1 ]
Chen, Peifeng [1 ]
Stein, Judith A. [1 ]
Carlton, Kevin [1 ]
Gall, Jason G. [1 ]
Nason, Martha C. [3 ]
Kwong, Peter D. [1 ]
Chen, Grace L. [1 ]
Mascola, John R. [1 ]
McLellan, Jason S. [4 ]
Ledgerwood, Julie E. [1 ]
Graham, Barney S. [1 ]
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] George Washington Univ, Inst Biomed Sci, Washington, DC 20052 USA
[3] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20852 USA
[4] Univ Texas Austin, Dept Mol Biosci, Coll Nat Sci, Austin, TX 78712 USA
[5] Cytek Biosci, Fremont, CA 94538 USA
[6] CRISPR Therapeut AG, Cambridge, MA 02139 USA
基金
美国国家卫生研究院;
关键词
RESPIRATORY SYNCYTIAL VIRUS; FUSION-GLYCOPROTEIN VACCINE; NEUTRALIZING ANTIBODIES; INFECTION; INFANTS; IMMUNIZATION; CHILDREN; TRIAL; RISK;
D O I
10.1126/science.aav9033
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Technologies that define the atomic-level structure of neutralization-sensitive epitopes on viral surface proteins are transforming vaccinology and guiding new vaccine development approaches. Previously, iterative rounds of protein engineering were performed to preserve the prefusion conformation of the respiratory syncytial virus (RSV) fusion (F) glycoprotein, resulting in a stabilized subunit vaccine candidate (DS-Cav1), which showed promising results in mice and macaques. Here, phase I human immunogenicity data reveal a more than 10-fold boost in neutralizing activity in serum from antibodies targeting prefusion-specific surfaces of RSV F. These findings represent a clinical proof of concept for structure-based vaccine design, suggest that development of a successful RSV vaccine will be feasible, and portend an era of precision vaccinology.
引用
收藏
页码:505 / +
页数:35
相关论文
共 32 条
[1]
A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age [J].
August, Allison ;
Glenn, Gregory M. ;
Kpamegan, Eloi ;
Hickman, Somia P. ;
Jani, Dewal ;
Lu, Hanxin ;
Thomas, D. Nigel ;
Wen, Judy ;
Piedra, Pedro A. ;
Fries, Louis F. .
VACCINE, 2017, 35 (30) :3749-3759
[2]
FIELD EVALUATION OF A RESPIRATORY SYNCYTIAL VIRUS VACCINE AND A TRIVALENT PARAINFLUENZA VIRUS VACCINE IN A PEDIATRIC POPULATION [J].
CHIN, J ;
MAGOFFIN, RL ;
SHEARER, LA ;
SCHIEBLE, JH ;
LENNETTE, EH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 89 (04) :449-+
[3]
Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults [J].
Falsey, AR ;
Walsh, EE .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (02) :463-466
[4]
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults [J].
Fries, Louis ;
Shinde, Vivek ;
Stoddard, Jeffrey J. ;
Thomas, D. Nigel ;
Kpamegan, Eloi ;
Lu, Hanxin ;
Smith, Gale ;
Hickman, Somia P. ;
Piedra, Pedro ;
Glenn, Gregory M. .
IMMUNITY & AGEING, 2017, 14
[5]
RESPIRATORY VIRUS IMMUNIZATION .I. A FIELD TRIAL OF 2 INACTIVATED RESPIRATORY VIRUS VACCINES - AN AQUEOUS TRIVALENT PARAINFLUENZA VIRUS VACCINE AND AN ALUM-PRECIPITATED RESPIRATORY SYNCYTIAL VIRUS VACCINE [J].
FULGINITI, VA ;
ELLER, JJ ;
SIEBER, OF ;
JOYNER, JW ;
MINAMITANI, M ;
MEIKLEJOHN, G .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 89 (04) :435-+
[6]
Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors [J].
Gilman, Morgan S. A. ;
Castellanos, Carlos A. ;
Chen, Man ;
Ngwuta, Joan O. ;
Goodwin, Eileen ;
Moin, Syed M. ;
Mas, Vicente ;
Melero, Jose A. ;
Wright, Peter F. ;
Graham, Barney S. ;
McLellan, Jason S. ;
Walker, Laura M. .
SCIENCE IMMUNOLOGY, 2016, 1 (06)
[7]
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein [J].
Gilman, Morgan S. A. ;
Moin, Syed M. ;
Mas, Vicente ;
Chen, Man ;
Patel, Nita K. ;
Kramer, Kari ;
Zhu, Qing ;
Kabeche, Stephanie C. ;
Kumar, Azad ;
Palomo, Concepcion ;
Beaumont, Tim ;
Baxa, Ulrich ;
Ulbrandt, Nancy D. ;
Melero, Jose A. ;
Graham, Barney S. ;
McLellan, Jason S. .
PLOS PATHOGENS, 2015, 11 (07)
[8]
RISK OF RESPIRATORY SYNCYTIAL VIRUS-INFECTION FOR INFANTS FROM LOW-INCOME FAMILIES IN RELATIONSHIP TO AGE, SEX, ETHNIC-GROUP, AND MATERNAL ANTIBODY LEVEL [J].
GLEZEN, WP ;
PAREDES, A ;
ALLISON, JE ;
TABER, LH ;
FRANK, AL .
JOURNAL OF PEDIATRICS, 1981, 98 (05) :708-715
[9]
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation [J].
Goodwin, Eileen ;
Gilman, Morgan S. A. ;
Wrapp, Daniel ;
Chen, Man ;
Ngwuta, Joan O. ;
Moin, Syed M. ;
Bai, Patricia ;
Sivasubramanian, Arvind ;
Connor, Ruth I. ;
Wright, Peter F. ;
Graham, Barney S. ;
McLellan, Jason S. ;
Walker, Laura M. .
IMMUNITY, 2018, 48 (02) :339-+
[10]
Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus [J].
Habibi, Maximillian S. ;
Jozwik, Agnieszka ;
Makris, Spyridon ;
Dunning, Jake ;
Paras, Allan ;
DeVincenzo, John P. ;
de Haan, Cornelis A. M. ;
Wrammert, Jens ;
Openshaw, Peter J. M. ;
Chiu, Christopher .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (09) :1040-1049